Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2
ML Brandi, RF Gagel, A Angeli… - The Journal of …, 2001 - academic.oup.com
… a consensus statement from an international group, mostly of clinical endocrinologists. MEN1
and MEN2 are hereditary cancer syndromes. … MEN1 is a syndrome causing combinations …
and MEN2 are hereditary cancer syndromes. … MEN1 is a syndrome causing combinations …
… treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome–an international consensus statement
B Niederle, A Selberherr, DK Bartsch, ML Brandi… - …, 2021 - karger.com
… Other features of MEN1 syndrome are tumors in the anterior pituitary (30–40%) and the
adrenal glands (in approximately 20–40%). Less frequently, MEN1-associated NENs are …
adrenal glands (in approximately 20–40%). Less frequently, MEN1-associated NENs are …
Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis
CDC Kamilaris, CA Stratakis - Frontiers in endocrinology, 2019 - frontiersin.org
… and treatment of MEN1-associated tumors, patients with this syndrome continue to have a
… There is no consensus on the optimal extent of surgical resection in patients with insulinoma…
… There is no consensus on the optimal extent of surgical resection in patients with insulinoma…
[PDF][PDF] MEN1 Surveillance guidelines: time to (Re) Think?
PJ Newey, J Newell-Price - Journal of the Endocrine Society, 2022 - academic.oup.com
… non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1
syndrome—an international consensus statement. Neuroendocrinology. 2021;111(7):609-630. …
syndrome—an international consensus statement. Neuroendocrinology. 2021;111(7):609-630. …
Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations
… MEN1 diagnosis (22): 1) the presence of one of the MEN1-associated tumors in a first-degree
relative of a patient with MEN1 syndrome; 2) the identification of a germline MEN1 … MEN1-…
relative of a patient with MEN1 syndrome; 2) the identification of a germline MEN1 … MEN1-…
The importance of an early and accurate MEN1 diagnosis
JM De Laat, RS Van Leeuwaarde… - Frontiers in …, 2018 - frontiersin.org
… There are either other syndromes that can cause a MEN1-like phenotype or sporadic co-…
consensus on the need for timely recognition of MEN1. First degree family members of MEN1 …
consensus on the need for timely recognition of MEN1. First degree family members of MEN1 …
Hereditary syndromes in neuroendocrine tumors
MA Lewis - Current Treatment Options in Oncology, 2020 - Springer
… Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome resulting
… feature of MEN1, with almost 100% penetrance by age fifty [2]. As such, many MEN1 patients …
… feature of MEN1, with almost 100% penetrance by age fifty [2]. As such, many MEN1 patients …
Screening guidelines and recommendations for patients at high risk of developing endocrine cancers
… Table 4 outlines expert consensus on suggested screening guidelines in patients … syndrome
is still being defined but is believed to mimic that of the more widely studied MEN1 syndrome…
is still being defined but is believed to mimic that of the more widely studied MEN1 syndrome…
Management impact: effects on quality of life and prognosis in MEN1
… The first consensus statement, edited by an international panel of specialists in the area of
MEN syndromes, was published in 2001 on both MEN1 and MEN2, according to data deriving …
MEN syndromes, was published in 2001 on both MEN1 and MEN2, according to data deriving …
ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes
RT Jensen, G Cadiot, ML Brandi, WW De Herder… - …, 2012 - karger.com
… mixed syndromes or tumors may change clinically over time. The most frequent familial
condition associated with RFT is MEN1, with glucagonomas occurring in 3% of MEN1 patients, …
condition associated with RFT is MEN1, with glucagonomas occurring in 3% of MEN1 patients, …